Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chapter 21. Additional polymorphisms and cancer.

M J Stubbins1, C R Wolf

  • 1GLP Clinical Genotyping Laboratory, Glaxo Wellcome Research and Development, Hertfordshire, United Kingdom.

IARC Scientific Publications
|September 24, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Defining the Contribution of CYP1A1 and CYP1A2 to Drug Metabolism Using Humanized CYP1A1/1A2 and Cyp1a1/Cyp1a2 Knockout Mice.

Drug metabolism and disposition: the biological fate of chemicals·2019
Same author

An Extensively Humanized Mouse Model to Predict Pathways of Drug Disposition and Drug/Drug Interactions, and to Facilitate Design of Clinical Trials.

Drug metabolism and disposition: the biological fate of chemicals·2019
Same author

MicroRNA-224 is associated with colorectal cancer progression and response to 5-fluorouracil-based chemotherapy by KRAS-dependent and -independent mechanisms.

British journal of cancer·2015
Same author

Glutathione S-transferase P1 (GSTP1) directly influences platinum drug chemosensitivity in ovarian tumour cell lines.

British journal of cancer·2014
Same author

Immunodetection of proteins by Western blotting.

Methods in molecular biology (Clifton, N.J.)·2012
Same author

Individuality in FGF1 expression significantly influences platinum resistance and progression-free survival in ovarian cancer.

British journal of cancer·2012
Same journal

North America.

IARC scientific publications·2016
Same journal

Central and South America.

IARC scientific publications·2016
Same journal

Africa.

IARC scientific publications·2016
Same journal

Data availability and presentation.

IARC scientific publications·2016
Same journal

Age standardization.

IARC scientific publications·2016
Same journal

Data processing.

IARC scientific publications·2016
See all related articles

This chapter explores understudied genes and their role in cancer susceptibility. It highlights the need for further research into genetic variations affecting carcinogen metabolism and cancer risk.

Area of Science:

  • Genetics
  • Molecular Biology
  • Cancer Research

Background:

  • Cytochrome P450 enzymes are crucial for detoxifying carcinogens.
  • Genetic variations (polymorphisms) in these genes can influence cancer susceptibility.
  • Phenotypic variations exist in specific populations, even without identified genetic polymorphisms.

Purpose of the Study:

  • To investigate less-studied genes and their significance in cancer susceptibility.
  • To identify knowledge gaps in the research of specific genes involved in carcinogen metabolism.
  • To highlight areas requiring future investigation for cancer risk assessment.

Main Methods:

  • Literature review and summary of existing research on gene-cancer susceptibility.
  • Analysis of studies on cytochrome P450 gene polymorphisms and phenotypic variations.

Related Experiment Videos

  • Identification of functional metabolic polymorphisms and their link to cancer risk.

    • Main Results:

    • Several less-studied genes show potential links to cancer susceptibility.
    • Defined phenotypic polymorphisms exist for some cytochrome P450 genes.
    • Gaps identified where functional polymorphisms are known, but cancer risk studies are lacking.

    Conclusions:

    • Further research is essential to fully understand the role of these genes in cancer susceptibility.
    • Investigating genetic and phenotypic variations in carcinogen-metabolizing genes is critical.
    • Targeted studies are needed to determine cancer risk associated with specific gene polymorphisms.